Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized nebulized therapy for moderate-to-severe acute asthma exacerbation in children
ChiCTR-TRC-13003343Phase 4Completed
- Sponsor
- State Key Laboratory of Respiratory Disease
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in asthma (2 arms), sponsored by State Key Laboratory of Respiratory Disease. Primary endpoints: hospital admission rate and need for systemic corticosteroids. Started Aug 2007; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-13003343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003343.